Not Yet RecruitingPhase 4ACTRN12606000092594

Evaluation of the clinical effectiveness of Safetac soft silicone dressings in the management of skin tears

Evaluation of the effect of safetac soft silicone dressings on healing rates of skin tears, and impact on peri-wound skin


Sponsor

Nursing Education & Research, Southern Health

Enrollment

400 participants

Start Date

May 1, 2006

Study Type

Interventional

Conditions

Summary

To objectively evaluate the efficacy of Safetac soft silicone dressings compared with standard treatment, on skin tear healing rates. Also to measure the impact of wound dressings on the surrounding skin. It is expected that a significantly greater proportion of patient skin tears treated with soft silicone will be healed, without trauma to the surrounding skin, at 7 days when compared with the group receiving standard treatment


Eligibility

Sex: Both males and femalesMin Age: 65 Yearss

Inclusion Criteria1

  • A skin tear sustained during hospitalisation.

Exclusion Criteria1

  • Pre-admission skin tears non-consenting patientspatients with behavioural problems with which may interfere with the wound dressing protocol.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A randomised prospective clinical trial.

A randomised prospective clinical trial. Safetac soft silicone coated dressings (Mepitel and Mepilex Border) after seven days of treatment.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000092594